AVALA and Dr. Stanislav Zhuk with Retina Associates New Orleans just made local history — performing the first ENCELTO™ procedure in Louisiana. This groundbreaking cell-based gene therapy offers new hope for adults living with Macular Telangiectasia Type 2, a rare retinal disease that, until now, had no approved treatment options. For patients facing progressive vision loss, ENCELTO™ represents more than innovation, it represents possibility. Discover how AVALA is leading the way in advancing care for rare retinal disorders, one breakthrough at a time. Read the full story here: avala.com/first-encelto-procedure-in-louisiana #avalahealth #InnovationInVision #GeneTherapy #MacTel #HealthcareInnovation